In contrast, the CD103+ DC subpopulation usually plays an important role in the autoimmune response and immune tolerance [68], so therapeutic strategies targeting this subpopulation can help slow down autoimmune diseases and the body’s destructive response to its tissues. The gene discussed is ITGAE; the disease is autoimmune disease.